Form 4: Cytokinetics VP, Chief Accounting Officer, Robert Wong, Sells Shares
SEC Form 4 Filing
Robert Wong, VP, Chief Accounting Officer of Cytokinetics Inc, sold 13,011 shares of common stock on June 3, 2024, at a price of $48.88 per share.
Summary
- On June 3, 2024, Robert Wong, the VP, Chief Accounting Officer of Cytokinetics Inc, sold 13,011 shares of the company's common stock.
- The sale was executed at a price of $48.88 per share.
- Following the transaction, Mr. Wong directly owns 16,653 shares of Cytokinetics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of an insider stock sale. The size of the sale is not significant relative to the company's market capitalization, and there's no indication of any specific negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. Investors often monitor these filings to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of the transaction: Robert Wong sold 13,011 shares of Cytokinetics Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.